<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03308539</url>
  </required_header>
  <id_info>
    <org_study_id>epicardial adipose tissue</org_study_id>
    <nct_id>NCT03308539</nct_id>
  </id_info>
  <brief_title>Prediction of Coronary Artery Disease Severity by Epicardial Adipose Tissue Thickness</brief_title>
  <official_title>Predictive Value of Epicardial Fat Thickness for Disease Severity in Coronary Artery Disease Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Osama Fekry</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      is to test the hypotheses that epicardial adipose tissue can be a marker of severity of
      coronary artery disease in myocardial infarction patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      epicardial adipose tissue is defined as the adipose tissue between the visceral pericardium
      and the outer margin of the myocardium which can be considered an endocrine organ that
      secretes pro-inflammatory and anti-inflammatory cytokines and chemokines including
      adiponectin.as investigators know, inflammatory response is an important factor in the
      coronary atherogenesis. Therefore,epicardial adipose tissue is likely to be connected with
      the severity of coronary artery disease.Recent studies showed that the thickness of the
      epicardial adipose tissue in patients with coronary artery disease was greater than that with
      normal coronary arteries.

      epicardial adipose tissue will be assessed using transthoracic echocardiography and cardiac
      magnetic resonance which allows for an accurate volumetric quantification of epicardial fat.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2017</start_date>
  <completion_date type="Anticipated">September 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>measurement of epicardial adipose tissue as marker of severity of coronary artery disease in myocardial infarction patients.</measure>
    <time_frame>one year</time_frame>
    <description>epicardial adipose tissue measurement using transthoracic echocardiography and cardiac magnetic resonance</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>myocardial infarction patients</arm_group_label>
    <description>transthoracic echocardiography and cardiac magnetic resonance</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>echocardiography and cardiac magnetic resonance</intervention_name>
    <description>transthoracic echocardiography and magnetic resonance imaging of the heart</description>
    <arm_group_label>myocardial infarction patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        acute myocardial infarction patiens not previously underwent percutaneous coronary
        angiography or coronary artery bypass grafting
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. Normal thoracic shape

          2. Sinus rhythm

          3. without severe respiratory diseases

        Exclusion Criteria:

          1. contraindication for cardiac magnetic resonance.

          2. Patients who previously underwent coronary artery bypass grafting or percutaneous
             coronary angiography prior to admission

          3. history of chronic kidney disease with glomerular filtration rate &lt;30 mL/min

          4. pericardial and/or pleural effusion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>jacqueline george, master</last_name>
    <phone>01275502685</phone>
    <phone_ext>assiut</phone_ext>
    <email>jacquelinegeorge@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>hosam hassan el araby, pofessor</last_name>
    <phone>01223971327</phone>
    <email>hosam_hasan@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jacqueline George</name>
      <address>
        <city>Assiut</city>
        <state>Single</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>hosam hassan, professor doctor</last_name>
      <phone>01223971327</phone>
      <email>hosam_hasan@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>heba el nagar, lecturer</last_name>
      <phone>01001963100</phone>
      <email>Heba_M_elnagar@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <results_reference>
    <citation>Desferrioxamine and transfusional iron overload. Lancet. 1978 Mar 4;1(8062):479-80.</citation>
    <PMID>76025</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2017</study_first_submitted>
  <study_first_submitted_qc>October 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2017</study_first_posted>
  <last_update_submitted>October 11, 2017</last_update_submitted>
  <last_update_submitted_qc>October 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Osama Fekry</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

